Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas- and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells

Authors
Publication date
1 January 2019
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    UCL Discovery

    redirect
    oaioai:eprints.ucl.ac.uk.OAI2:100...
    Last time updated on 31/05/2019